Skip to main content
. 2016 May 3;63(3):396–403. doi: 10.1093/cid/ciw277

Table 1.

Characteristics of Cohortsa

Characteristic Patients, No. (%)b
Cohort A (n = 3933) Cohort B (n = 2163) Cohort C (n = 611)
Age, y
 18–24 252 (6.4) 130 (6.0) 71 (11.6)
 25–34 805 (20.5) 391 (18.1) 147 (24.1)
 35–44 978 (24.9) 541 (25.0) 140 (22.9)
 45–54 1371 (34.9) 799 (36.9) 188 (30.8)
 55–64 527 (13.4) 302 (14.0) 65 (10.6)
Race/ethnicity
 American Indian/Alaska Native/Native Hawaiian 25 (0.6) 17 (0.8) 10 (1.6)
 Asian 67 (1.7) 37 (1.7) 3 (0.5)
 Black/African American 2601 (66.1) 2523 (65.3) 435 (71.2)
 Hispanic/Latino 266 (6.8) 175 (8.1) 39 (6.4)
 White 974 (24.8) 522 (24.1) 124 (20.3)
Sex
 Female 1086 (27.6) 639 (29.5) 178 (29.1)
 Transgender 27 (0.7) 7 (0.3) 3 (0.5)
 Male 2820 (71.7) 522 (24.1) 124 (20.3)
HIV/AIDS diagnosis
 AIDS diagnosis 1433 (36.4) 876 (40.5) 240 (39.3)
 HIV diagnosis 2500 (63.6) 1287 (59.5) 371 (60.7)
2013 ADAP plan
 PCIP 399 (10.1) 141 (6.5) 26 (4.3)
 Direct ADAP 3534 (89.9) 2022 (93.5) 585 (95.7)
Financial status
 251%–400% FPL (tax credit) 201 (5.1) 138 (6.4) 38 (6.2)
 139%–250% FPL (tax credit) 677 (17.2) 376 (17.4) 76 (12.4)
 101%–138% FPL (Medicaid gap with tax credit) 462 (11.7) 285 (11.9) 58 (9.5)
 <100% FPL (Medicaid gap, no Tax Credit) 2593 (65.9) 1391 (64.3) 439 (71.8)
Virginia region of residence
 Northwest 339 (8.6) 220 (10.2) 52 (8.5)
 Eastern 1379 (35.1) 439 (20.3) 191 (31.3)
 Central 1011 (25.7) 681 (31.5) 195 (31.9)
 Southwest 357 (9.1) 236 (10.9) 66 (10.8)
 Northern 847 (21.5) 587 (27.1) 107 (17.5)
CD4 cell count, mean (SD), cells/μL 554 (322)c 555 (319)d 409 (295)e
Time since HIV diagnosis, mean (SD), y 9.2 (6.7)f 9.6 (6.7)g 9.5 (7.0)h

Abbreviations: ADAP, AIDS Drug Assistance Program; FPL, federal poverty level; HIV, human immunodeficiency virus; PCIP, Pre-existing Condition Insurance Plan; SD, standard deviation.

a Cohort A includes people living with HIV who were 18–64 years old on 1 January 2013, were ADAP clients by 1 July 2013, did not receive Medicare, and had a Social Security number. Cohort B includes members of cohort A who demonstrated consistent engagement in care, as defined by ≥1 HIV viral load (VL) recorded in 2014 and ≥1 VL between 1 July 2014 and 31 December 2014. Cohort C includes members of cohort B who had an initial detectable VL in 2013, indicating suboptimally controlled HIV disease.

b Data represent No. (%) of patients, unless otherwise specified.

c Data available for 3684 subjects in cohort A.

d Data available for 2162 subjects in cohort B.

e Data available for 610 subjects in cohort C.

f Data available for 3381 subjects in cohort A.

g Data available for 1926 subjects in cohort B.

h Data available for 490 subjects in cohort C.